Unravelling the Proteomics of HLA-B*57:01(+) Antigen Presenting Cells during Abacavir Medication

Type B adverse drug reactions (ADRs) are unpredictable based on the drug’s pharmacology and represent a key challenge in pharmacovigilance. For human leukocyte antigen (HLA)-mediated type B ADRs, it is assumed that the protein/small-molecule interaction alters the biophysical and mechanistic propert...

Descripción completa

Detalles Bibliográficos
Autores principales: Haukamp, Funmilola Josephine, Gall, Eline, Hò, Gia-Gia Toni, Hiemisch, Wiebke, Stieglitz, Florian, Kuhn, Joachim, Blasczyk, Rainer, Pich, Andreas, Bade-Döding, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781935/
https://www.ncbi.nlm.nih.gov/pubmed/35055355
http://dx.doi.org/10.3390/jpm12010040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781935/
https://www.ncbi.nlm.nih.gov/pubmed/35055355
http://dx.doi.org/10.3390/jpm12010040

Ejemplares similares